SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 240 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $2,695,000 | -90.0% | 15,594 | -93.4% | 0.04% | -89.2% |
Q4 2014 | $27,031,000 | +234.0% | 235,171 | +354.0% | 0.42% | +280.7% |
Q3 2014 | $8,093,000 | -16.6% | 51,799 | -34.1% | 0.11% | -3.5% |
Q2 2014 | $9,701,000 | -0.2% | 78,647 | -16.2% | 0.11% | +1.8% |
Q1 2014 | $9,720,000 | +6.6% | 93,814 | -7.5% | 0.11% | +5.7% |
Q4 2013 | $9,122,000 | +29.9% | 101,421 | -3.5% | 0.10% | +114.3% |
Q3 2013 | $7,025,000 | -2.4% | 105,046 | -3.4% | 0.05% | -41.7% |
Q2 2013 | $7,197,000 | – | 108,796 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |